Durbin
340B "hasn’t really cut the profits of the pharmaceutical companies dramatically,” U.S. Senate Majority Whip Dick Durbin (D-Ill.) said during a visit to a Chicago community health center.

Senate Democratic Whip Durbin: 340B Hasn’t Cut Pharma Profits Dramatically

The 340B program “is a really successful program and it hasn’t really cut the profits of the pharmaceutical companies dramatically,” U.S. Senate Majority Whip Dick Durbin (D-Ill.) said Friday during a visit to a Chicago-based community health center.

Durbin is the second ranking Democratic senator after Majority Leader Chuck Schumer (D-N.Y.) and takes the lead in solidifying support for Senate Democratic initiatives. He was accompanied by U.S. Rep. Delia Ramirez (D-Ill.) as they traveled to one of Erie Family Health Center’s 13 Chicago-area locations to speak about lowering drug costs and addressing health care workforce shortages.

The 340B program “is a really successful program and it hasn’t really cut the profits of the pharmaceutical companies dramatically,” U.S. Senate Majority Whip Dick Durbin (D-Ill.) said Friday during a visit to a Chicago-based community health center.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer